PWMG
MBRX icon

Prestige Wealth Management Group’s Moleculin Biotech MBRX Stock Holding History

Prestige Wealth Management Group’s Portfolio MBRX Stock Details MBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Hold
0
– – – 1021
2021
Q4 		– Hold
0
– – – 1032
2021
Q3 		– Hold
0
– – – 909
2021
Q2 		– Hold
0
– – – 898
2021
Q1 		– Hold
0
– – – 889
2020
Q4 		– Hold
0
– – – 862
2020
Q3 		– Hold
0
– – – 800
2020
Q2 		– Hold
0
– – – 802
2020
Q1 		– Hold
0
– – – 790
2019
Q4 		– Hold
0
– – – 539
2019
Q3 		– Hold
0
– – – 546
2019
Q2 		– Hold
0
– – – 475

Other funds holding MBRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return